| 12473360 |
Multi-specific antibody constructs |
Jay M. Short, Hwai Wen Chang |
2025-11-18 |
|
| 12427347 |
Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof |
Jay M. Short, Hwai Wen Chang |
2025-09-30 |
|
| 12311032 |
Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof |
Jay M. Short, Hwai Wen Chang |
2025-05-27 |
|
| 12252535 |
Antibody molecules to LAG-3 and uses thereof |
Frederic Triebel, Chrystelle Brignone, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton +1 more |
2025-03-18 |
|
| 12186278 |
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy |
Jennifer Brogdon, Hwai Wen Chang, Boris Engels, Gordon J. Freeman, Jennifer Marie Mataraza +2 more |
2025-01-07 |
|
| 12187801 |
Chimeric antigen receptors against AXL or ROR2 and methods of use thereof |
Gregory I. Frost, James Onuffer, Jay M. Short, Hwai Wen Chang |
2025-01-07 |
|
| 12110611 |
Conditionally active biological proteins |
Jay M. Short, Hwai Wen Chang |
2024-10-08 |
$3,003,000 |
| 11897959 |
Anti-AXL antibodies, antibody fragments and their immunoconjugates and uses thereof |
Jay M. Short, Hwai Wen Chang |
2024-02-13 |
$2,919,000 |
| 11879011 |
Anti-ROR2 antibodies, antibody fragments, their immunoconjucates and uses thereof |
Jay M. Short, Hwai Wen Chang |
2024-01-23 |
$2,203,000 |
| 11859007 |
Humanized anti-CD73 antibodies |
Emily Piccione Griffin, Richard A. Miller, Hwai Wen Chang |
2024-01-02 |
$2,481,000 |
| 11851499 |
Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof |
Jay M. Short, Hwai Wen Chang |
2023-12-26 |
$2,865,000 |
| 11834472 |
Anti-IL-22 antibodies, antibody fragments, their immunoconjugates and uses thereof |
Jay M. Short, Hwai Wen Chang, William J. Boyle |
2023-12-05 |
$1,582,000 |
| 11827704 |
Antibody molecules to PD-1 and uses thereof |
Gordon J. Freeman, Arlene H. Sharpe, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton +1 more |
2023-11-28 |
$128,707,000 |
| 11773509 |
Conditionally active polypeptides and methods of generating them |
Jay M. Short, Hwai Wen Chang |
2023-10-03 |
$1,723,000 |
| 11718844 |
Mirac proteins |
Jay M. Short, Hwai Wen Chang |
2023-08-08 |
$4,061,000 |
| 11542332 |
Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof |
Jay M. Short, Hwai Wen Chang |
2023-01-03 |
$12,176,000 |
| 11472876 |
Conditionally active polypeptides |
Jay M. Short, Hwai Wen Chang |
2022-10-18 |
$7,747,000 |
| 11413340 |
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy |
Jennifer Brogdon, Hwai Wen Chang, Boris Engels, Gordon J. Freeman, Jennifer Marie Mataraza +2 more |
2022-08-16 |
$39,265,000 |
| 11292834 |
Therapeutic CD47 antibodies |
William A. Frazier, Pamela T. Manning, Hwai Wen Chang, Robert W. KARR |
2022-04-05 |
|
| 11279924 |
Conditionally active polypeptides and methods of generating them |
Jay M. Short, Hwai Wen Chang |
2022-03-22 |
$2,688,000 |
| 11254932 |
Conditionally active biological proteins |
Jay M. Short, Hwai Wen Chang |
2022-02-22 |
$1,821,000 |
| 11254742 |
Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof |
Jay M. Short, Hwai Wen Chang |
2022-02-22 |
$1,821,000 |
| 11149088 |
Anti-Axl antibodies, antibody fragments and their immunoconjugates and uses thereof |
Jay M. Short, Hwai Wen Chang |
2021-10-19 |
$15,274,000 |
| 11111288 |
Conditionally active chimeric antigen receptors for modified t-cells |
Jay M. Short, Hwai Wen Chang |
2021-09-07 |
$20,126,000 |
| 10954288 |
Modified antibody regions and uses thereof |
Jay M. Short, Hwai Wen Chang |
2021-03-23 |
$36,186,000 |
